Who’s the bad guy? Become a better health reporter by bringing together ethics and standards of investigative journalism and Evidence-based medicine (EBM) GalleryWho’s the bad guy? Become a better health reporter by bringing together ethics and standards of investigative journalism and Evidence-based medicine (EBM)
Approvals - Homologations, Clinical trials - Essais cliniques, Conflict of interest - Conflits d’intérêts, Training - Enseignement
Who’s the bad guy? Become a better health reporter by bringing together ethics and standards of investigative journalism and Evidence-based medicine (EBM)
Re-Check joined the European Investigative Journalism Conference, that took place in Mechelen, Belgium, In May 2018. We were honored to have the chance to teach one day long to a [...]
Isotretinoin: health system failures
Do not miss Wednesday, October 18, 2017 the broadcast in French on RTS (the program is “36,9”) of Serena Tinari’s investigative report about a case involving isotretinoin (*). Serena Tinari’s [...]
Winding back the harms of too much medicine: Re-Check joined the 5th Preventing Overdiagnosis Conference in Québec City GalleryWinding back the harms of too much medicine: Re-Check joined the 5th Preventing Overdiagnosis Conference in Québec City
Adverse effects - Effets indésirables, Approvals - Homologations, Breast cancer screening - Dépistage du cancer du sein, Clinical trials - Essais cliniques, Endometriosis - Endométriose, HPV - HPV/VPH, HPV vaccine - Vaccination anti-HPV, Overdiagnosis - Surdiagnostic-
-
-
-
Winding back the harms of too much medicine: Re-Check joined the 5th Preventing Overdiagnosis Conference in Québec City
Catherine Riva of Re-Check was selected by the organizers of the Conference to present the results of her investigation on the “mammo-business”, an extensive system of business models and careers [...]
The crossroads between Evidence Based Medicine and investigation
The crossroads between Evidence Based Medicine and investigation: Re-Check training day in Fribourg (Switzerland) With Catherine Riva and Serena Tinari (Re-Check), Thomas Angeli (Lobbywatch), Manolo Luppichini (reporter) and Prof. Thierry [...]
Overkill?
By Abby Lippman, Professor Emerita, Department of Epidemiology, Biostatistics and Occupational Health, McGill University; Research Associate, Simone de Beauvoir Institute, Concordia University Published on bioethiqueonline.ca, 14 Jun 2017 Sometimes, perhaps [...]
HPV testing: big business
HPV testing is now recommended in several countries (In Holland and USA, for example) to replace the Pap test (cytology) for primary screening of cervical cancer. Roche is one of [...]